Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells

Clinical Science

Volumn 106, Issue 6, 2004, Pages 619-625

  Yamauchi, Yasuhiro ^a   Okazaki, Hitoshi ^a   Desaki, Masashi ^a   Kohyama, Tadashi ^a   Kawasaki, Shin ^a   Yamamoto, Kazuhiko ^a   Takizawa, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alveolar epithelial cells; Bronchial epithelial cells; Interleukin 8; Methotrexate; p38 mitogen activated; Pneumonitis

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; CYCLOHEXIMIDE; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE P38; THREONINE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS CELL; PNEUMONIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; BRONCHI; CELL LINE; CYCLOHEXIMIDE; EPITHELIAL CELLS; FOLIC ACID ANTAGONISTS; FREE RADICAL SCAVENGERS; GLUCOSE; HUMANS; HYPOGLYCEMIA; INTERLEUKIN-1; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; METHOTREXATE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITORS; PULMONARY ALVEOLI; THREONINE; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 2942744911     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030262     Document Type: Article

References (36)

1. Lynch, III, J. P. and McCune, J. (1997) Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am. J. Respir. Crit. Care Med. 155, 395-420
2. Cooper, Jr, J. A., White, D. A. and Matthay, R. A. (1986) Drug-induced pulmonary disease: Cytotoxic drugs. I. Am. Rev. Respir. Dis. 133, 321-340
3. Imokawa, S., Colby, T. V., Leslie, K. O. and Helmers, R. A. (2000) Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur. Respir. J. 15, 373-381
4. White, D. A., Rankin, J. A., Stover, D. E., Gellene, R. A. and Gupta, S. (1989) Methotrexate pneumonitis: Bronchoalveolar lavage fluid findings suggest an immunologic disorder. Am. Rev. Respir. Dis. 139, 18-21
5. Schnabel, A., Richter, C., Bauerfeind, S. and Gross, W. L. (1997) Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 52, 377-379
6. Fuhrman, C., Parrot, A., Cadranel, J. et al. (2001) Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis. Am. J. Respir. Crit. Care Med. 164, 1186-1191
7. Yoshida, S., Onuma, K., Amayasu, H. et al. (1999) Elevated levels of IL-8 in interstitial pneumonia induced by low-dose methotrexate. J. Allergy Clin. Immunol. 103, 952-954
8. Leduc, D., De Vuyst, P., Lheureux, P., Gevenois, P. A., Jacobovitz, D. and Yernault, J. C. (1993) Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings. Chest 104, 1620-1623
9. Yoshimura, T., Matsushima, K., Oppenheim, J. J. and Leonard, E. J. (1987) Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin-1 (IL1). J. Immunol. 39, 788-793
10. Standiford, T. J., Kunkel, S. L., Basha, M. A. et al. (1990) Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest. 86, 1945-1953
11. Koyama, S., Sato, E., Takamizawa, A. et al. (2003) Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities. Exp. Lung Res. 29, 91-111
12. Alarcon, G. S., Kremer, J. M., Macaluso, M. et al. (1997) Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis: a multicenter, case-control study. Ann. Intern. Med. 127, 356-364
13. Furst, D. E., Koehnke, R., Burmeister, L. F., Kohler, J. and Cargill, I. (1989) Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J. Rheumatol. 16, 313-320
14. Golden, M. R., Katz, R. S., Balk, R. A. and Golden, H. E. (1995) The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J. Rheumatol. 22, 1043-1047
15. Rosenow, III, E. C. (1994) Drug induced pulmonary disease. Dis. Mon. 40, 253-310
16. St Clair, E. W., Rice, J. R. and Snyderman, R. (1985) Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch. Intern. Med. 145, 2035-2038
17. Carroll, G. R., Thomas, R., Phatouros, C. C. et al. (1994) Incidence, prevalence, and possible risk factors for pneumonitis with rheumatoid arthritis receiving methotrexate. J. Rheumatol. 21, 51-54
18. Pearson, G., Robinson, F., Gibson, T. B. et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183
19. Han, J., Lee, J. D., Bibbs, L. and Ulevitch, R. J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science (Washington, D.C.) 265, 808-811
20. Raingeaud, J., Gupta, S., Rogers, J. S. et al. (1995) Proinflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426
21. Hashimoto, S., Gon, Y., Takeshita, K. et al. (2000) Diesel Exhaust Particles Activate p38 MAP kinase to produce interleukin 8 and RANTES by human bronchial epithelial cells and N-acetylcysteine attenuates p38 MAP kinase activation. Am. J. Respir. Crit. Care Med. 162, 280-285
22. Matsumoto, K., Hashimoto, S., Gon, Y., Nakayama, T. and Horie, T. (1998) Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase pathway. J. Allergy Clin. Immunol. 101, 825-831
23. Hashimoto, S., Matsumoto, K., Gon, Y., Nakayama, T., Takeshita, I. and Horie, T. (1999) Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase. Am. J. Respir. Crit. Care Med. 159, 634-640
24. Takizawa, H., Ohtoshi, T., Kudo, S. et al. (1999) Diesel exhaust particles induced NF-κB activation in human bronchial epithelial cells in vitro: importance in cytokine transcription. J. Immunol. 162, 4705-4711
25. Ichijo, H. (1999) From receptors to stress-activated MAP kinases. Oncogene 18, 6087-6093
26. Takizawa, H., Abe, S., Okazaki, H. et al. (2003) Diesel exhaust particles upregulate eotaxin gene expression in human bronchial epithelial cells via nuclear factor-κB-dependent pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L1055-L1062
27. Takizawa, H., Desaki, M., Ohtoshi, T. et al. (1997) Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 156, 266-271
28. Bannwarth, B., Pehourcq, F., Schaeverbeke, T. and Dehais, J. (1996) Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin. Pharmacokinet. 30, 194-210
29. Desoky, E. E. L., Khalifa, M. M. A., Mahmoud, J. A., Ebraheem, S. A. T. and Klotz, U. (1997) Disposition and clinical efficacy of methotrexate in patients with rheumatoid arthritis following weekly, low, intramuscular dosing: a pilot study. Curr. Ther. Res. 58, 434-445
30. Phelps, D. T., Deneke, S. M., Daley, D. L. and Fanburg, B. L. (1992) Elevation of glutathione levels in bovine pulmonary artery endothelial cells by N-acetylcysteine. Am. J. Respir. Cell Mol. Biol. 7, 293-299
31. Blackwell, T. S., Blackwell, T. R., Holden, E. P., Christman, B. W. and Christman, J. W. (1996) In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J. Immunol. 157, 1630-1637
32. Clerk, A., Fuller, S. J., Michael, A. and Sugden, P. H. (1998) Stimulation of 'stress-regulated' mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J. Biol. Chem. 273, 7228-7234
33. Whitmarsh, A. J. and Davis, R. J. (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74, 589-607
34. Wesselborg, S., Bauer, M. K., Vogt, M., Schmitz, M. L. and Schulze-Osthoff, K. (1997) Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272, 12422-12429
35. Cuenda, A., Rouse, J., Doza, Y. N. et al. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233
36. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494